Market Overview
The global Gene Therapy in Oncology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Gene Therapy in Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gene Therapy in Oncology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Gene Therapy in Oncology market has been segmented into Ex Vivo, In Vivo, etc.
Breakdown by Application, Gene Therapy in Oncology has been segmented into Hospitals, Diagnostics Centers, Research Institutes, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gene Therapy in Oncology market presented in the report. This section sheds light on the sales growth of different regional and country-level Gene Therapy in Oncology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gene Therapy in Oncology market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Gene Therapy in Oncology Market Share Analysis
Gene Therapy in Oncology competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Gene Therapy in Oncology revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gene Therapy in Oncology revenue and market share for each player covered in this report.
The major players covered in Gene Therapy in Oncology are: Bristol-Myers Squibb, Editas Medicine, Amgen, Cold Genesys, CRISPR Therapeutics, Advantagene, Idera Pharmaceuticals, Bio-Path Holdings, AstraZeneca, Geron Corp, Mologen AG, Oncotelic, Intellia Therapeutics, Sillajen Biotherapeutics, Oncolytics Biotech, Merck, Johnson & Johnson, Shenzhen SiBiono GeneTech, Oncosec, Marsala Biotech, Tocagen, UniQure, Ziopharm Oncology, etc. Among other players domestic and global, Gene Therapy in Oncology market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Bristol-Myers Squibb
Editas Medicine
Amgen
Cold Genesys
CRISPR Therapeutics
Advantagene
Idera Pharmaceuticals
Bio-Path Holdings
AstraZeneca
Geron Corp
Mologen AG
Oncotelic
Intellia Therapeutics
Sillajen Biotherapeutics
Oncolytics Biotech
Merck
Johnson & Johnson
Shenzhen SiBiono GeneTech
Oncosec
Marsala Biotech
Tocagen
UniQure
Ziopharm Oncology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Ex Vivo
In Vivo
Market segment by Application, can be divided into
Hospitals
Diagnostics Centers
Research Institutes
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gene Therapy in Oncology
1.2 Classification of Gene Therapy in Oncology by Type
1.2.1 Overview: Global Gene Therapy in Oncology Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Gene Therapy in Oncology Revenue Market Share by Type in 2019
1.2.3 Ex Vivo
1.2.4 In Vivo
1.3 Global Gene Therapy in Oncology Market by Application
1.3.1 Overview: Global Gene Therapy in Oncology Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Global Gene Therapy in Oncology Market Size and Forecast (2015-2025)
1.5 Global Gene Therapy in Oncology Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Gene Therapy in Oncology Market Size by Regions (2015-2020)
1.7 Global Gene Therapy in Oncology Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Gene Therapy in Oncology Status and Prospect (2015-2025)
1.7.2 Europe Gene Therapy in Oncology Status and Prospect (2015-2025)
1.7.3 Asia Gene Therapy in Oncology Status and Prospect (2015-2025)
1.7.4 South America Gene Therapy in Oncology Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Gene Therapy in Oncology Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Editas Medicine
2.2.1 Editas Medicine Details
2.2.2 Editas Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Editas Medicine SWOT Analysis
2.2.4 Editas Medicine Product and Services
2.2.5 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cold Genesys
2.4.1 Cold Genesys Details
2.4.2 Cold Genesys Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cold Genesys SWOT Analysis
2.4.4 Cold Genesys Product and Services
2.4.5 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.5 CRISPR Therapeutics
2.5.1 CRISPR Therapeutics Details
2.5.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CRISPR Therapeutics SWOT Analysis
2.5.4 CRISPR Therapeutics Product and Services
2.5.5 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Advantagene
2.6.1 Advantagene Details
2.6.2 Advantagene Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Advantagene SWOT Analysis
2.6.4 Advantagene Product and Services
2.6.5 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Idera Pharmaceuticals
2.7.1 Idera Pharmaceuticals Details
2.7.2 Idera Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Idera Pharmaceuticals SWOT Analysis
2.7.4 Idera Pharmaceuticals Product and Services
2.7.5 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio-Path Holdings
2.8.1 Bio-Path Holdings Details
2.8.2 Bio-Path Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio-Path Holdings SWOT Analysis
2.8.4 Bio-Path Holdings Product and Services
2.8.5 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AstraZeneca SWOT Analysis
2.9.4 AstraZeneca Product and Services
2.9.5 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.10 Geron Corp
2.10.1 Geron Corp Details
2.10.2 Geron Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Geron Corp SWOT Analysis
2.10.4 Geron Corp Product and Services
2.10.5 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mologen AG
2.11.1 Mologen AG Details
2.11.2 Mologen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mologen AG SWOT Analysis
2.11.4 Mologen AG Product and Services
2.11.5 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.12 Oncotelic
2.12.1 Oncotelic Details
2.12.2 Oncotelic Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Oncotelic SWOT Analysis
2.12.4 Oncotelic Product and Services
2.12.5 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.13 Intellia Therapeutics
2.13.1 Intellia Therapeutics Details
2.13.2 Intellia Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Intellia Therapeutics SWOT Analysis
2.13.4 Intellia Therapeutics Product and Services
2.13.5 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.14 Sillajen Biotherapeutics
2.14.1 Sillajen Biotherapeutics Details
2.14.2 Sillajen Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Sillajen Biotherapeutics SWOT Analysis
2.14.4 Sillajen Biotherapeutics Product and Services
2.14.5 Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.15 Oncolytics Biotech
2.15.1 Oncolytics Biotech Details
2.15.2 Oncolytics Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Oncolytics Biotech SWOT Analysis
2.15.4 Oncolytics Biotech Product and Services
2.15.5 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.16 Merck
2.16.1 Merck Details
2.16.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Merck SWOT Analysis
2.16.4 Merck Product and Services
2.16.5 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.17 Johnson & Johnson
2.17.1 Johnson & Johnson Details
2.17.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Johnson & Johnson SWOT Analysis
2.17.4 Johnson & Johnson Product and Services
2.17.5 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.18 Shenzhen SiBiono GeneTech
2.18.1 Shenzhen SiBiono GeneTech Details
2.18.2 Shenzhen SiBiono GeneTech Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Shenzhen SiBiono GeneTech SWOT Analysis
2.18.4 Shenzhen SiBiono GeneTech Product and Services
2.18.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.19 Oncosec
2.19.1 Oncosec Details
2.19.2 Oncosec Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Oncosec SWOT Analysis
2.19.4 Oncosec Product and Services
2.19.5 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.20 Marsala Biotech
2.20.1 Marsala Biotech Details
2.20.2 Marsala Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Marsala Biotech SWOT Analysis
2.20.4 Marsala Biotech Product and Services
2.20.5 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.21 Tocagen
2.21.1 Tocagen Details
2.21.2 Tocagen Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Tocagen SWOT Analysis
2.21.4 Tocagen Product and Services
2.21.5 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.22 UniQure
2.22.1 UniQure Details
2.22.2 UniQure Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 UniQure SWOT Analysis
2.22.4 UniQure Product and Services
2.22.5 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.23 Ziopharm Oncology
2.23.1 Ziopharm Oncology Details
2.23.2 Ziopharm Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Ziopharm Oncology SWOT Analysis
2.23.4 Ziopharm Oncology Product and Services
2.23.5 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Gene Therapy in Oncology Market Size by Players (2015-2020)
3.2 United States Gene Therapy in Oncology Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Gene Therapy in Oncology Players Market Share
3.3.2 Top 10 Gene Therapy in Oncology Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Gene Therapy in Oncology Market Size by Countries (2015-2020)
4.2 North America Gene Therapy in Oncology Market Size and Forecast by Countries (2015-2026)
4.3 United States Gene Therapy in Oncology Market Size and Forecast (2015-2025)
4.4 Canada Gene Therapy in Oncology Market Size and Forecast (2015-2025)
4.5 Mexico Gene Therapy in Oncology Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Gene Therapy in Oncology Market Size by Countries (2015-2020)
5.2 Europe Gene Therapy in Oncology Market Size and Forecast by Countries (2015-2026)
5.3 Germany Gene Therapy in Oncology Market Size and Forecast (2015-2025)
5.4 France Gene Therapy in Oncology Market Size and Forecast (2015-2025)
5.5 UK Gene Therapy in Oncology Market Size and Forecast (2015-2025)
5.6 Russia Gene Therapy in Oncology Market Size and Forecast (2015-2025)
5.7 Italy Gene Therapy in Oncology Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Gene Therapy in Oncology Market Size by Regions (2015-2020)
6.2 Asia-Pacific Gene Therapy in Oncology Market Size and Forecast by Regions (2015-2026)
6.3 China Gene Therapy in Oncology Market Size and Forecast (2015-2025)
6.4 Japan Gene Therapy in Oncology Market Size and Forecast (2015-2025)
6.5 Korea Gene Therapy in Oncology Market Size and Forecast (2015-2025)
6.6 India Gene Therapy in Oncology Market Size and Forecast (2015-2025)
6.7 Southeast Asia Gene Therapy in Oncology Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Gene Therapy in Oncology Market Size by Countries (2015-2020)
7.2 South America Gene Therapy in Oncology Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Gene Therapy in Oncology Market Size and Forecast (2015-2025)
7.4 Argentina Gene Therapy in Oncology Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Gene Therapy in Oncology Revenue by Regions (2015-2020)
8.2 Middle East & Africa Gene Therapy in Oncology Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Gene Therapy in Oncology Market Size and Forecast (2015-2025)
8.4 UAE Gene Therapy in Oncology Market Size and Forecast (2015-2025)
8.5 Egypt Gene Therapy in Oncology Market Size and Forecast (2015-2025)
8.6 South Africa Gene Therapy in Oncology Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Gene Therapy in Oncology Market Size and Forecast by Type (2015-2025)
9.1.1 Global Gene Therapy in Oncology Market Size by Type (2015-2020)
9.1.2 Global Gene Therapy in Oncology Market Size Forecast by Type (2020-2025)
9.2 United States Gene Therapy in Oncology Market Size and Forecast by Type (2015-2025)
9.2.1 United States Gene Therapy in Oncology Market Size by Type (2015-2020)
9.2.2 United States Gene Therapy in Oncology Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Gene Therapy in Oncology Market Size and Forecast by Application (2015-2025)
10.1.1 Global Gene Therapy in Oncology Market Size by Application (2015-2020)
10.1.2 Global Gene Therapy in Oncology Market Size Forecast by Application (2020-2025)
10.2 United States Gene Therapy in Oncology Market Size and Forecast by Application (2015-2025)
10.2.1 United States Gene Therapy in Oncology Market Size by Application (2015-2020)
10.2.2 United States Gene Therapy in Oncology Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Gene Therapy in Oncology Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Gene Therapy in Oncology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gene Therapy in Oncology Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Gene Therapy in Oncology Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Gene Therapy in Oncology Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Gene Therapy in Oncology Revenue Share by Regions (2015-2020)
Table 7. Global Gene Therapy in Oncology Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Gene Therapy in Oncology Revenue Market Share by Regions (2020-2025)
Table 9. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 10. Bristol-Myers Squibb Major Business
Table 11. Bristol-Myers Squibb Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 12. Bristol-Myers Squibb SWOT Analysis
Table 13. Bristol-Myers Squibb Gene Therapy in Oncology Product and Solutions
Table 14. Bristol-Myers Squibb Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Editas Medicine Corporate Information, Location and Competitors
Table 16. Editas Medicine Major Business
Table 17. Editas Medicine Gene Therapy in Oncology Total Revenue (USD Million) (2018-2019)
Table 18. Editas Medicine SWOT Analysis
Table 19. Editas Medicine Gene Therapy in Oncology Product and Solutions
Table 20. Editas Medicine Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Amgen Corporate Information, Location and Competitors
Table 22. Amgen Major Business
Table 23. Amgen Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 24. Amgen SWOT Analysis
Table 25. Amgen Gene Therapy in Oncology Product and Solutions
Table 26. Amgen Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Cold Genesys Corporate Information, Location and Competitors
Table 28. Cold Genesys Major Business
Table 29. Cold Genesys Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 30. Cold Genesys SWOT Analysis
Table 31. Cold Genesys Gene Therapy in Oncology Product and Solutions
Table 32. Cold Genesys Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. CRISPR Therapeutics Corporate Information, Location and Competitors
Table 34. CRISPR Therapeutics Major Business
Table 35. CRISPR Therapeutics Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 36. CRISPR Therapeutics SWOT Analysis
Table 37. CRISPR Therapeutics Gene Therapy in Oncology Product and Solutions
Table 38. CRISPR Therapeutics Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Advantagene Corporate Information, Location and Competitors
Table 40. Advantagene Major Business
Table 41. Advantagene Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 42. Advantagene SWOT Analysis
Table 43. Advantagene Gene Therapy in Oncology Product and Solutions
Table 44. Advantagene Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Idera Pharmaceuticals Corporate Information, Location and Competitors
Table 46. Idera Pharmaceuticals Major Business
Table 47. Idera Pharmaceuticals Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 48. Idera Pharmaceuticals SWOT Analysis
Table 49. Idera Pharmaceuticals Gene Therapy in Oncology Product and Solutions
Table 50. Idera Pharmaceuticals Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Bio-Path Holdings Corporate Information, Location and Competitors
Table 52. Bio-Path Holdings Major Business
Table 53. Bio-Path Holdings Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 54. Bio-Path Holdings SWOT Analysis
Table 55. Bio-Path Holdings Gene Therapy in Oncology Product and Solutions
Table 56. Bio-Path Holdings Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. AstraZeneca Corporate Information, Location and Competitors
Table 58. AstraZeneca Major Business
Table 59. AstraZeneca Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 60. AstraZeneca SWOT Analysis
Table 61. AstraZeneca Gene Therapy in Oncology Product and Solutions
Table 62. AstraZeneca Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Geron Corp Corporate Information, Location and Competitors
Table 64. Geron Corp Major Business
Table 65. Geron Corp Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 66. Geron Corp SWOT Analysis
Table 67. Geron Corp Gene Therapy in Oncology Product and Solutions
Table 68. Geron Corp Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Mologen AG Corporate Information, Location and Competitors
Table 70. Mologen AG Major Business
Table 71. Mologen AG Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 72. Mologen AG SWOT Analysis
Table 73. Mologen AG Gene Therapy in Oncology Product and Solutions
Table 74. Mologen AG Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Oncotelic Corporate Information, Location and Competitors
Table 76. Oncotelic Major Business
Table 77. Oncotelic Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 78. Oncotelic SWOT Analysis
Table 79. Oncotelic Gene Therapy in Oncology Product and Solutions
Table 80. Oncotelic Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. Intellia Therapeutics Corporate Information, Location and Competitors
Table 82. Intellia Therapeutics Major Business
Table 83. Intellia Therapeutics Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 84. Intellia Therapeutics SWOT Analysis
Table 85. Intellia Therapeutics Gene Therapy in Oncology Product and Solutions
Table 86. Intellia Therapeutics Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. Sillajen Biotherapeutics Corporate Information, Location and Competitors
Table 88. Sillajen Biotherapeutics Major Business
Table 89. Sillajen Biotherapeutics Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 90. Sillajen Biotherapeutics SWOT Analysis
Table 91. Sillajen Biotherapeutics Gene Therapy in Oncology Product and Solutions
Table 92. Sillajen Biotherapeutics Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. Oncolytics Biotech Corporate Information, Location and Competitors
Table 94. Oncolytics Biotech Major Business
Table 95. Oncolytics Biotech Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 96. Oncolytics Biotech SWOT Analysis
Table 97. Oncolytics Biotech Gene Therapy in Oncology Product and Solutions
Table 98. Oncolytics Biotech Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. Merck Corporate Information, Location and Competitors
Table 100. Merck Major Business
Table 101. Merck Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 102. Merck SWOT Analysis
Table 103. Merck Gene Therapy in Oncology Product and Solutions
Table 104. Merck Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. Johnson & Johnson Corporate Information, Location and Competitors
Table 106. Johnson & Johnson Major Business
Table 107. Johnson & Johnson Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 108. Johnson & Johnson SWOT Analysis
Table 109. Johnson & Johnson Gene Therapy in Oncology Product and Solutions
Table 110. Johnson & Johnson Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 111. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Type and Application
Table 112. Shenzhen SiBiono GeneTech Major Business
Table 113. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 114. Shenzhen SiBiono GeneTech SWOT Analysis
Table 115. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product and Solutions
Table 116. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 117. Oncosec Corporate Information, Location and Competitors
Table 118. Oncosec Major Business
Table 119. Oncosec Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 120. Oncosec SWOT Analysis
Table 121. Oncosec Gene Therapy in Oncology Product and Solutions
Table 122. Oncosec Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 123. Marsala Biotech Corporate Information, Location and Competitors
Table 124. Marsala Biotech Major Business
Table 125. Marsala Biotech Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 126. Marsala Biotech SWOT Analysis
Table 127. Marsala Biotech Gene Therapy in Oncology Product and Solutions
Table 128. Marsala Biotech Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 129. Tocagen Corporate Information, Location and Competitors
Table 130. Tocagen Major Business
Table 131. Tocagen Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 132. Tocagen SWOT Analysis
Table 133. Tocagen Gene Therapy in Oncology Product and Solutions
Table 134. Tocagen Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 135. UniQure Corporate Information, Location and Competitors
Table 136. UniQure Major Business
Table 137. UniQure Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 138. UniQure SWOT Analysis
Table 139. UniQure Gene Therapy in Oncology Product and Solutions
Table 140. UniQure Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 141. Ziopharm Oncology Corporate Information, Location and Competitors
Table 142. Ziopharm Oncology Major Business
Table 143. Ziopharm Oncology Gene Therapy in Oncology Total Revenue (USD Million) (2017-2018)
Table 144. Ziopharm Oncology SWOT Analysis
Table 145. Ziopharm Oncology Gene Therapy in Oncology Product and Solutions
Table 146. Ziopharm Oncology Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 147. Global Gene Therapy in Oncology Revenue (USD Million) by Players (2015-2020)
Table 148. Global Gene Therapy in Oncology Revenue Share by Players (2015-2020)
Table 149. Key Players Gene Therapy in Oncology Revenue (USD Million) in United States (2015-2020)
Table 150. Key Players Gene Therapy in Oncology Revenue Share in United States (2015-2020)
Table 151. North America Gene Therapy in Oncology Revenue (USD Million) by Countries (2015-2020)
Table 152. North America Gene Therapy in Oncology Revenue Market Share by Countries (2015-2020)
Table 153. North America Gene Therapy in Oncology Revenue (USD Million) by Countries (2020-2026)
Table 154. North America Gene Therapy in Oncology Revenue Market Share by Countries (2020-2026)
Table 155. Europe Gene Therapy in Oncology Revenue (USD Million) by Countries (2015-2020)
Table 156. Europe Gene Therapy in Oncology Revenue Market Share by Countries (2015-2020)
Table 157. Europe Gene Therapy in Oncology Revenue (USD Million) by Countries (2020-2026)
Table 158. Europe Gene Therapy in Oncology Revenue Market Share by Countries (2020-2026)
Table 159. Asia-Pacific Gene Therapy in Oncology Revenue (USD Million) by Countries (2015-2020)
Table 160. Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries (2015-2020)
Table 161. Asia-Pacific Gene Therapy in Oncology Revenue (USD Million) by Countries (2020-2026)
Table 162. Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries (2020-2026)
Table 163. South America Gene Therapy in Oncology Revenue (USD Million) by Countries (2015-2020)
Table 164. South America Gene Therapy in Oncology Revenue Market Share by Countries (2015-2020)
Table 165. South America Gene Therapy in Oncology Revenue (USD Million) by Countries (2020-2026)
Table 166. South America Gene Therapy in Oncology Revenue Market Share by Countries (2020-2026)
Table 167. Middle East & Africa Gene Therapy in Oncology Revenue (USD Million) by Countries (2015-2020)
Table 168. Middle East & Africa Gene Therapy in Oncology Revenue Market Share by Countries (2015-2020)
Table 169. Middle East & Africa Gene Therapy in Oncology Revenue (USD Million) by Countries (2020-2026)
Table 170. Middle East & Africa Gene Therapy in Oncology Revenue Market Share by Countries (2020-2026)
Table 171. Global Gene Therapy in Oncology Revenue (USD Million) by Type (2015-2020)
Table 172. Global Gene Therapy in Oncology Revenue Share by Type (2015-2020)
Table 173. Global Gene Therapy in Oncology Revenue Forecast by Type (2020-2025)
Table 174. Global Gene Therapy in Oncology Market Share Forecast by Type (2020-2025)
Table 175. United States Gene Therapy in Oncology Revenue (USD Million) by Type (2015-2020)
Table 176. United States Gene Therapy in Oncology Revenue Share by Type (2015-2020)
Table 177. United States Gene Therapy in Oncology Revenue Forecast by Type (2020-2025)
Table 178. United States Gene Therapy in Oncology Market Share Forecast by Type (2020-2025)
Table 179. Global Gene Therapy in Oncology Revenue (USD Million) by Application (2015-2020)
Table 180. Global Gene Therapy in Oncology Revenue Share by Application (2015-2020)
Table 181. Global Gene Therapy in Oncology Revenue Forecast by Application (2020-2025)
Table 182. Global Gene Therapy in Oncology Market Share Forecast by Application (2020-2025)
Table 183. United States Gene Therapy in Oncology Revenue (USD Million) by Application (2015-2020)
Table 184. United States Gene Therapy in Oncology Revenue Share by Application (2015-2020)
Table 185. United States Gene Therapy in Oncology Revenue Forecast by Application (2020-2025)
Table 186. United States Gene Therapy in Oncology Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Gene Therapy in Oncology Picture
Figure 2. Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Gene Therapy in Oncology Revenue Market Share by Type in 2019
Figure 4. Ex Vivo Picture
Figure 5. In Vivo Picture
Figure 6. Gene Therapy in Oncology Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Diagnostics Centers Picture
Figure 9. Research Institutes Picture
Figure 10. Global Gene Therapy in Oncology Revenue and Growth Rate (2015-2025) (USD Million)
Figure 11. Global Gene Therapy in Oncology Market Size Share by Regions (2015-2025)
Figure 12. Global Gene Therapy in Oncology Market Size Share by Regions in 2019
Figure 13. Global Gene Therapy in Oncology Revenue Market Share by Regions (2020-2025)
Figure 14. North America Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. Europe Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. South America Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. Middle East & Africa Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. Global Gene Therapy in Oncology Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Gene Therapy in Oncology Revenue Market Share in 2019
Figure 21. Top 10 Players Gene Therapy in Oncology Revenue Market Share in Global Market in 2019
Figure 22. Global Gene Therapy in Oncology Market Size (USD Million) by Type (2015-2025)
Figure 23. Global Gene Therapy in Oncology Market Size Share by Application (2015-2025)
Figure 24. North America Gene Therapy in Oncology Market Size Share by Countries (2015-2025)
Figure 25. North America Gene Therapy in Oncology Market Size Share by Countries in 2019
Figure 26. United States Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 27. Canada Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 28. Mexico Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 29. Europe Gene Therapy in Oncology Market Size Share by Countries (2015-2025)
Figure 30. Europe Gene Therapy in Oncology Market Size Share by Countries in 2019
Figure 31. Germany Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 32. France Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 33. Russia Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 34. Italy Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Spain Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 36. UK Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Asia Gene Therapy in Oncology Market Size Share by Countries (2015-2025)
Figure 38. Asia Gene Therapy in Oncology Market Size Share by Countries in 2019
Figure 39. China Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 40. Japan Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 41. Korea Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 42. India Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 43. Southeast Asia Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 44. South America Gene Therapy in Oncology Market Size Share by Countries (2015-2025)
Figure 45. South America Gene Therapy in Oncology Market Size Share by Countries in 2019
Figure 46. Brazil Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 47. Argentina Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 48. Middle East & Africa Gene Therapy in Oncology Market Size Share by Countries (2015-2025)
Figure 49. Middle East & Africa Gene Therapy in Oncology Market Size Share by Countries in 2019
Figure 50. Saudi Arabia Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 51. UAE Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 52. Egypt Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 53. South Africa Gene Therapy in Oncology Market Size (USD Million) and Forecast (2015-2025)
Figure 54. Global Gene Therapy in Oncology Revenue Share by Type (2015-2020)
Figure 55. United States Gene Therapy in Oncology Revenue Share by Type (2015-2020)
Figure 56. Global Gene Therapy in Oncology Revenue Share by Application (2015-2020)
Figure 57. United States Gene Therapy in Oncology Revenue Share by Application (2015-2020)
